...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question on valuing shares from time of spinoff

https://www.resverlogix.com/about/history

Share
New Message
Please login to post a reply